Lotus Pharmaceutical Co., Ltd. (TPE:1795)
304.00
-10.00 (-3.18%)
At close: Jan 21, 2026
17.83% (1Y)
| Market Cap | 79.95B |
| Revenue (ttm) | 18.66B |
| Net Income (ttm) | 4.73B |
| Shares Out | 262.98M |
| EPS (ttm) | 18.04 |
| PE Ratio | 16.85 |
| Forward PE | 11.87 |
| Dividend | 5.78 (1.84%) |
| Ex-Dividend Date | Aug 11, 2025 |
| Volume | 5,363,474 |
| Average Volume | 4,130,655 |
| Open | 315.50 |
| Previous Close | 314.00 |
| Day's Range | 302.50 - 317.00 |
| 52-Week Range | 172.50 - 344.50 |
| Beta | 0.20 |
| RSI | 53.96 |
| Earnings Date | Mar 4, 2026 |